Delayed treatment with nicotinamide (vitamin B 3) reduces the infarct volume following focal cerebral ischemia in spontaneously hypertensive rats, diabetic and non-diabetic Fischer

Brain Research

Volumn 931, Issue 1, 2002, Pages 68-73

  Sakakibara, Yohtaro ^a   Mitha, Alim P ^a   Ayoub, Issam A ^a   Ogilvy, Christopher S ^a   Maynard, Kenneth I ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b SANOFI   (France)

Author keywords

Diabetes; Hypertention; Neuroprotection; Niacinamide; Ploy(ADP polymerase inhibitor; Stroke

Indexed keywords

NICOTINAMIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIABETES MELLITUS; HYPERGLYCEMIA; HYPERTENSION; MALE; NEUROPROTECTION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RAT; RAT STRAIN; REDUCTION; RISK FACTOR; STROKE;

ANIMALS; BLOOD GAS ANALYSIS; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; DIABETES MELLITUS, EXPERIMENTAL; HYPERGLYCEMIA; MALE; MIDDLE CEREBRAL ARTERY; NIACINAMIDE; RATS; RATS, INBRED F344; RATS, INBRED SHR; RISK FACTORS;

EID: 0037155479     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)02263-1     Document Type: Article

References (45)

1. Nicotinamide reduces infarction up to 2 h after the onset of permanent focal cerebral ischemia in Wistar rats
2. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate
3. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats
4. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model
5. Animal models of diabetes mellitus: Physiology and pathology
6. Coenzyme nicotinamide adenine dinucleotide: A new therapeutic approach for improving dementia of the Alzheimer's type
7. Nicotinamide adenine dinucleotide: A new therapeutic approach to Parkinson's disease
8. Neuroprotection after focal cerebral ischemia in hyperglycaemic and diabetic rats
9. Magnetic resonance imaging of perfusion in rat cerebral 9L tumor after nicotinamide administration
10. Effects of isradipine, an L-type calcium channel blocker, on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats
11. Genetic and gender influences on sensitivity to focal cerebral ischemia in the stroke-prone spontaneously hypertensive rat
12. Different susceptibilities to cerebral infarction in spontaneously hypertensive (SHR) and normotensive Sprague-Dawley rats
13. Temporal impairment of microcirculatory perfusion following focal cerebral ischemia in the spontaneously hypertensive rat
14. Intraluminal suture occlusion of the middle cerebral artery in spontaneously hypertensive rats
15. Protective effects of memantine against ischemia-reperfusion injury in spontaneously hypertensive rats
16. The quantification of cerebral infarction following focal ischemia in the rat: Influence of strain, arterial pressure, blood glucose concentration, and age
17. Ischemic brain injury is mediated by the activation of poly (ADP-ribose) polymerase
18. Rodent models of cerebral ischemia
19. Acute treatment of hypertension increases infarct sizes in spontaneously hypertensive rats
20. Nicotinamide pharmacokinetics in humans and mice: A comparative assessment and the implications for radiotherapy
21. Influence of hyperglycemia on cerebral adenosine production during ischemia and reperfusion
22. Nicotinamide attenuates methamphetamine-induced striatal dopamine depletion in rats
23. The effect of niacinamide on cerebral circulation
24. Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide
25. Nicotinamide in type 1 diabetes: Mechanism of action revisited
26. Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia
27. Prevention of nitric oxide-induced neuronal injury through the modulation of independent pathways of programmed cell death
28. Inhibition of poly (ADP-ribose) polymerase: Reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation
29. Delayed multidose treatment with nicotinamide extends the degree and duration of neuroprotection by reducing infarction and improving behavioral scores up to 2 weeks following transient focal cerebral ischemia in Wistar rats
30. Delayed treatment with nicotinamide (vitamin B3) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats
31. Increased plasma tryptophan in HIV-infected patients treated with pharmacologic doses of nicotinamide
32. Focal ischemia of the rat brain, with special reference to the influence of plasma glucose concentration
33. Hyperglycemia protects against neuronal injury around experimental brain infarcts
34. Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus
35. Effect of MK-801 on focal brain infarction in normotensive and hypertensive rats
36. Post-treatment with nicotinamide (vitamin B3) reduces the infarct volume following permanent focal cerebral ischemia in female Sprague-Dawley and Wistar rats
37. Hypertension and hyperglycemia in experimental stroke
38. Niacin and niacinamide transport in the central nervous system. In vivo studies
39. Substrates of energy metabolism attenuate methamphetamine-induced neurotoxity in striatum
40. Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers
41. A semiautomated method for measuring brain infarct volume
42. Neuroprotective effects of inhibiting poly (ADP-ribose) synthetase on focal cerebral ischemia in rats
43. Post-treatment with an inhibitor of poly (ADP-ribose) polymerase attenuates cerebral damage in focal ischemia
44. Structural and functional changes in cerebral arteries from spontaneously hypertensive rats
45. Probability of stroke: A risk profile from the Framingham study